Pediatrix Q2 Revenue Rises 4% to $487.8 Million Despite Volume Decline

โดย Zacks Investment Research·

Summary · why it matters

Pediatrix Medical Group reported second-quarter 2026 net revenues of $487.8 million, up 4% year over year, as acquisitions and higher same-unit pricing offset a 2.1% decline in same-unit revenues tied to patient volume. Same-unit revenues from net reimbursement-related factors rose 4% year over year, helped by improved revenue-cycle management cash collections, a favorable payor mix and higher patient acuity, primarily in neonatology, while commercial and other non-government payor mix improved 135 basis points from the year-ago period. Adjusted EBITDA increased to $76.4 million from $73.2 million, and the company reaffirmed its 2026 adjusted EBITDA outlook of $280-$300 million. Pediatrix expects full-year patient volumes to be roughly flat to slightly lower, and the benefit from stronger revenue-cycle collections is expected to ease in the second half of 2026, while higher salaries and malpractice expenses could weigh on operating leverage. Among peers, Tenet Healthcare posted a 6% year-over-year increase in hospital unit net operating revenues with admissions up 2.3%, and HCA Healthcare reported admissions up 2.4% with revenue per equivalent admission up 6%.